跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EVENITY romosozumab 105 mg/1.17 mL injection solution syringe - TGA Drug Approval Details
Approvals
/
TGA
/
EVENITY romosozumab 105 mg/1.17 mL injection solution syringe
Approved
STANDARD
EVENITY romosozumab 105 mg/1.17 mL injection solution syringe
Amgen Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
7ea4a22e93fad2e3
Company
Amgen Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
7ea4a22e93fad2e3
Product Name
EVENITY romosozumab 105 mg/1.17 mL injection solution syringe
Artg Id
296831
Artg Name
EVENITY romosozumab 105 mg/1.17mL injection solution syringe
Sponsor
Amgen Australia Pty Ltd
Company Detail Path
/organization/amgen-australia-pty-ltd
Artg Date
2019-07-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/78fe0d6b533c277a1858ee9311798a81.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/bcaf9507264461b63bca94a90d48a344.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
7ea4a22e93fad2e3
Type
Standard
Back to TGA Approvals